Acting On Alpha-1, 4-glucosidic Bond, (e.g., Hyaluronidase, Invertase, Amylase, Etc. (some 3.2.1)) Patents (Class 435/201)
  • Publication number: 20140127307
    Abstract: The present invention relates to a small particle size composition comprising pancreatin containing digestive enzymes for use in patients in need, including pediatric, geriatric, and adult patients, particularly those patients with dysphagia or wherein enteral administration using such composition would be suitable. In addition, the invention is directed to the composition as particles, such as micropellets or microgranules having a high potency, high useable yield and at least 10%-90% of 400-800 ?m. Furthermore, the composition optionally has an improved enteric coating and concomitant improved stability and enzyme activity compared to conventional prepared enterically coated pancreatic enzyme particles.
    Type: Application
    Filed: November 2, 2012
    Publication date: May 8, 2014
    Applicant: APTALIS PHARMA LIMITED
    Inventors: Gopi M. VENKATESH, Craig Kramer, Flavio Fabiani, Luigi Mapelli, Giovanni Ortenzi, Massimo Latino
  • Patent number: 8703465
    Abstract: A truncated pullulanase variant of a parent pullulanase belonging to family GH57 comprising an X47 domain and the use thereof.
    Type: Grant
    Filed: December 22, 2010
    Date of Patent: April 22, 2014
    Assignee: Novozymes A/S
    Inventors: Martin Borchert, Morten Gjermansen, Suzanne Clark, Bernard Henrissat, Maria B. Silow, Peter F. Hallin
  • Patent number: 8697066
    Abstract: Disclosed herein are methods of using extracellular matrix digesting enzymes and neurotoxins, such as a Clostridial neurotoxins, to treat various medical conditions, such as overactive bladder, benign prostatic hyperplasia, hyperhidrosis, for example.
    Type: Grant
    Filed: January 31, 2013
    Date of Patent: April 15, 2014
    Assignee: Allergan, Inc.
    Inventors: Franklin D. Gaylis, Andrew M. Blumenfeld
  • Patent number: 8680248
    Abstract: Improved host cells and culture methods involving overexpression of MAN1C1 activity to improve protein production are provided.
    Type: Grant
    Filed: May 30, 2013
    Date of Patent: March 25, 2014
    Assignee: Amgen Inc.
    Inventor: Christopher Kenyon Crowell
  • Publication number: 20140069866
    Abstract: A zinc compound and methods for use in removing phosphate from water. Preferably the compound is used in removing phosphate from water in swimming pools, spas, and similar structures. Several water treatment techniques are disclosed, as well as a variety of different methods for delivery of the active ingredients. These delivery methods include use of a slurry of the active reagent in solution as well as a tablet, powder, or granulated structure. Additionally, the water treatment techniques may incorporate the use of a combination including both enzymatic compositions and compounds for phosphate removal.
    Type: Application
    Filed: November 15, 2013
    Publication date: March 13, 2014
    Applicant: Natural Chemistry L.P.
    Inventor: Richard Okun
  • Publication number: 20140065127
    Abstract: Methicillin-resistant (MRSA) and multi-drug resistant strains of Staphylococcus aureus are becoming increasingly prevalent in both human and veterinary clinics. S. aureus-causing bovine mastitis yields high annual losses to the dairy industry. Treatment of mastitis by broad range antibiotics is often not successful and may contribute to development of antibiotic resistance. Bacteriophage endolysins are a promising new source of antimicrobials. The endolysin of prophage ?SH2 of Staphylococcus haemolyticus strain JCSC1435 (?SH2 lysin) shows lytic activity against live staphylococcal cells. Deletion constructs were tested in zymograms and turbidity reduction assays to evaluate the contribution of each functional module to lysis. The CHAP domain exhibited three-fold higher activity than the full length protein. Activity was further enhanced in the presence of bivalent calcium ions.
    Type: Application
    Filed: September 6, 2012
    Publication date: March 6, 2014
    Inventors: David M. Donovan, Igor V. Abaev, Mathias Schmelcher
  • Publication number: 20140051119
    Abstract: The present invention provides fungal xylanase and/or beta-xylosidase enzymes suitable for use in saccharification reactions. The present application further provides genetically modified fungal organisms that produce xylanase and/or beta-xylosidases, as well as enzyme mixtures exhibiting enhanced hydrolysis of cellulosic material to fermentable sugars, enzyme mixtures produced by the genetically modified fungal organisms, and methods for producing fermentable sugars from cellulose using such enzyme mixtures.
    Type: Application
    Filed: June 10, 2013
    Publication date: February 20, 2014
    Applicant: Codexis, Inc.
    Inventors: Ryan Fong, Xiyun Zhang, Chirs Noriega, Nicholas Agard, Anupam Gohel, Derek Smith
  • Publication number: 20140045222
    Abstract: To provide novel ?-amylase derived from a microorganism and a gene thereof. ?-amylase derived from Bacillus flexus is provided.
    Type: Application
    Filed: June 17, 2013
    Publication date: February 13, 2014
    Applicant: Amano Enzyme Inc.
    Inventors: Akiko Matsunaga, Hitoshi Amano, Shotaro Yamaguchi
  • Publication number: 20140045223
    Abstract: The present invention relates to isolated polypeptides having isoamylase activity derived from Dyella japonica and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. The invention also relates to the use of said polypeptide having isoamylase activity for producing glucose syrup, fructose syrup, maltose syrup or maltitol.
    Type: Application
    Filed: October 11, 2013
    Publication date: February 13, 2014
    Applicant: Novozymes A/S
    Inventors: Tine Hoff, Carsten Sjoeholm, Barrie Edmund Norman
  • Publication number: 20140038242
    Abstract: The present invention relates to isolated polypeptides having isoamylase activity derived from Dyella japonica and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides. The invention also relates to the use of said polypeptide having isoamylase activity for producing glucose syrup, fructose syrup, maltose syrup or maltitol.
    Type: Application
    Filed: October 11, 2013
    Publication date: February 6, 2014
    Applicant: NOVOZYMES A/S
    Inventors: Tine Hoff, Carsten Sjoeholm, Barrie Edmund Norman
  • Publication number: 20140033373
    Abstract: The invention relates to a polypeptide comprising the amino acid sequence set out in SEQ ID NO: 2 or an amino acid sequence encoded by the nucleotide sequence of SEQ ID NO: 1, or a variant polypeptide or variant polynucleotide thereof, wherein the variant polypeptide has at least 73% sequence identity with the sequence set out in SEQ ID NO: 2 or the variant polynucleotide encodes a polypeptide that has at least 73% sequence identity with the sequence set out in SEQ ID NO: 2. The invention features the full length coding sequence of the novel gene as well as the amino acid sequence of the full-length functional polypeptide and functional equivalents of the gene or the amino acid sequence. The invention also relates to methods for using the polypeptide in industrial processes. Also included in the invention are cells transformed with a polynucleotide according to the invention suitable for producing these proteins.
    Type: Application
    Filed: June 23, 2011
    Publication date: January 30, 2014
    Applicant: DSM IP ASSETS B.V.
    Inventors: Margot Elisabeth Francoise Schooneveld-Bergmans, Wilbert Herman Marie Heijne, Monica Diana Vlasie, Robbertus Antonius Damveld
  • Patent number: 8637293
    Abstract: Provided herein is an isolated Cel7A polypeptide comprising mutations in the catalytic domain of the polypeptide relative to the catalytic domain of a wild type Cel7A polypeptide, wherein the mutations reduce N-linked glycosylation of the isolated polypeptide relative to the wild type polypeptide. Also provided herein is an isolated Cel7A polypeptide comprising increased O-linked glycosylation of the linker domain relative to a linker domain of a wild type Cel7A polypeptide. The increased O-linked glycosylation is a result of the addition of and/or substitution of one or more serine and/or threonine residues to the linker domain relative to the linker domain of the wild type polypeptide. In some embodiments, the isolated Cel7A polypeptide comprising mutations in the catalytic domain of the polypeptide relative to the catalytic domain of a wild type Cel7A polypeptide further comprises increased O-linked glycosylation of the linker domain relative to a linker domain of a wild type Cel7A polypeptide.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: January 28, 2014
    Assignee: Alliance for Sustainable Energy, LLC
    Inventors: William S. Adney, Michael E. Himmel, Stephen R. Decker, Eric P. Knoshaug, Mark R. Nimlos, Michael F. Crowley, Tina Jeoh
  • Patent number: 8633012
    Abstract: Methods and compositions for the production of oil, fuels, oleochemicals, and other compounds in recombinant microorganisms are provided, including oil-bearing microorganisms and methods of low cost cultivation of such microorganisms. Microalgal cells containing exogenous genes encoding, for example, a lipase, a sucrose transporter, a sucrose invertase, a fructokinase, a polysaccharide-degrading enzyme, a keto acyl-ACP synthase enzyme, a fatty acyl-ACP thioesterase, a fatty acyl-CoA/aldehyde reductase, a fatty acyl-CoA reductase, a fatty aldehyde reductase, a fatty acid hydroxylase, a desaturase enzyme, a fatty aldehyde decarbonylase, and/or an acyl carrier protein are useful in manufacturing transportation fuels such as renewable diesel, biodiesel, and renewable jet fuel, as well as oleochemicals such as functional fluids, surfactants, soaps and lubricants.
    Type: Grant
    Filed: October 11, 2012
    Date of Patent: January 21, 2014
    Assignee: Solazyme, Inc.
    Inventors: Scott Franklin, Aravind Somanchi, Janice Wee, George Rudenko, Jeffrey L. Moseley, Walt Rakitsky, Xinhua Zhao, Riyaz Bhat
  • Publication number: 20140017224
    Abstract: The present invention relates to a polypeptide with endolysin activity comprising an amino acid sequence according to SEQ ID No. 1 and fragments or derivatives thereof, or fusion proteins derived thereof. Moreover, the present invention relates to nucleic acid molecules encoding said polypeptide or fusion protein, vectors comprising said nucleic acid molecules and host cells comprising either said nucleic acid molecules or said vectors. In addition, the present invention relates to said polypeptide, fragment, derivative or fusion protein for use as a medicament, in particular for the treatment or prevention of Gram-negative bacterial infections, as diagnostic means, as cosmetic substance or as sanitizing agent.
    Type: Application
    Filed: November 3, 2011
    Publication date: January 16, 2014
    Applicants: UNIVERSITY OF MINHO, KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D
    Inventors: Joana Cecilia Valente Rodrigues Azeredo, Silvio Roberto Branco Dos Santos, Leonardus Dorothea Kluskens, Rob Lavigne, Maarten Walmagh
  • Patent number: 8617852
    Abstract: A method is described for producing a target substance utilizing a microorganism by culturing the microorganism in a medium to produce and accumulate the target substance in the medium, and then collecting the target substance from culture. The microorganism is imparted with isomaltase activity, or modified to increase isomaltase activity.
    Type: Grant
    Filed: July 9, 2010
    Date of Patent: December 31, 2013
    Assignee: Ajinomoto Co., Inc.
    Inventors: Ryo Takeshita, Naoki Kadotani, Kenji Abe
  • Publication number: 20130333072
    Abstract: The present invention relates to isolated polypeptides having glucoamylase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Application
    Filed: November 30, 2010
    Publication date: December 12, 2013
    Applicants: Novozymes North America, Inc., Novozymes A/S
    Inventors: Sara Landvik, Keiichi Ayabe, Guillermo Coward-Kelly
  • Publication number: 20130330781
    Abstract: The present invention relates to enzyme preparations consisting essentially of an enzyme which has cellulytic activity, which perform very well in industrial applications such as laundry compositions, for biopolishing of newly manufactured textiles, for providing an abraded look of cellulosic fabric or garment, and for treatment of paper pulp. Further, the invention relates to DNA constructs encoding such enzymes, a method for providing a gene encoding for such enzymes, a method of producing the enzymes, enzyme preparations containing such enzymes, and the use of these enzymes for a number of industrial applications.
    Type: Application
    Filed: November 21, 2012
    Publication date: December 12, 2013
    Applicant: NOVOZYMES A/S
    Inventors: Martin Schulein, Lene Nonboe Andersen, Soren Flensted Lassen, Markus Sakari Kauppinen, Lene Lange, Ruby Ilum Nielsen, Shinobu Takagi, Michiko Ihara
  • Patent number: 8597927
    Abstract: The invention provides methods, compositions, and kits for removal of biofilms from surfaces. The methods described herein comprise simultaneous or sequential application of a perhydrolase enzyme and a mixture of other enzymes, such as proteases, glucanases, esterases, mannanases, phospholipases, cellulases, and/or amylases, to a biofilm on a surface, to effect removal of the biofilm.
    Type: Grant
    Filed: December 16, 2008
    Date of Patent: December 3, 2013
    Assignee: Danisco US Inc.
    Inventors: Christopher C. Barnett, Manoj Kumar, Gregory M. Whited
  • Patent number: 8597919
    Abstract: The present invention relates to methods for producing high levels of alcohol during fermentation of plant material, and to the high alcohol beer produced. The method can include selecting plant material. Selecting can include excluding plant material that has been exposed to high temperatures or that has had high moisture content.
    Type: Grant
    Filed: March 8, 2011
    Date of Patent: December 3, 2013
    Assignee: Poet Research, Inc.
    Inventor: Stephen M. Lewis
  • Publication number: 20130302879
    Abstract: The present invention relates to the use of glycosyl hydrolase family (61) polypeptides in the presence of cellulases for textile manufacture as well as a textile composition comprising glycosyl hydrolase family (61) polypeptides and cellulases.
    Type: Application
    Filed: December 14, 2011
    Publication date: November 14, 2013
    Applicant: Novozymes A/S
    Inventors: Weijan Lai, Guifang Wu
  • Publication number: 20130302275
    Abstract: Modified PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.
    Type: Application
    Filed: December 28, 2012
    Publication date: November 14, 2013
    Inventors: Ge Wei, H. Michael Shepard, Qiping Zhao, Robert James Connor
  • Patent number: 8580538
    Abstract: Ethylenically unsaturated glycosides of the formula I: wherein n, A, X, R3 and R4 have the meanings given in the description are produced by reacting an ethylenically unsaturated alcohol of formula II: with a saccharide of formula III: in the presence of a glucosidase at a molar ratio of the alcohol to the saccharide of from 2:1 to 30:1 in the presence of a solvent mixture of water and 1,4-dioxane at a weight ratio of 0.1:1 to 9:1 and a weight ratio of solvent mixture to saccharide of from 3:1 to 30:1.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: November 12, 2013
    Assignee: BASF SE
    Inventors: Harald Keller, Katja Loos, Wouter Kloosterman
  • Patent number: 8569033
    Abstract: A method for suppressing a reduction in an endoglucanase activity in the presence of a surfactant, characterized by modifying a protein having the endoglucanase activity in which the N-terminus is an amino acid other than pyroglutamic acid, to a protein having the N-terminus of pyroglutamic acid, is disclosed. Further, a modified protein having an endoglucanase activity wherein the N-terminal amino acid is converted into pyroglutamic acid by an amino acid modification, a polynucleotide encoding the protein, an expression vector comprising the polynucleotide, a host cell transformed with the expression vector, and a process for producing the protein by cultivating the host cell, are disclosed.
    Type: Grant
    Filed: December 7, 2004
    Date of Patent: October 29, 2013
    Assignee: Meiji Seika Pharma Co., Ltd.
    Inventors: Manabu Watanabe, Koji Yanai, Yumiko Tsuyuki
  • Publication number: 20130273026
    Abstract: A method and composition for treating in a mammalian subject a condition accompanied or caused by IgE mediated histamine release from mast cells comprising administering to a subject in need of such treatment a therapeutically effective amount of the pharmaceutical composition an amylase peptide or derivative thereof.
    Type: Application
    Filed: April 12, 2013
    Publication date: October 17, 2013
    Inventors: Madhavi Gavini, Raja Srinivas
  • Publication number: 20130273632
    Abstract: To provide novel ?-amylase derived from a microorganism and a gene thereof. ?-amylase derived from Bacillus flexus is provided.
    Type: Application
    Filed: June 17, 2013
    Publication date: October 17, 2013
    Inventors: Akiko Matsunaga, Hitoshi Amano, Shotaro Yamaguchi
  • Publication number: 20130273611
    Abstract: Compositions and methods are provided for treating lignocellulosic material with a xylanase enzyme having xylanase activity. The enzyme is stable and active at increased pHs and temperatures. The present invention therefore provides methods for hydrolyzing lignocellulosic material, especially cellulose and hemicellulose, which are major components of the cell wall of non-woody and woody plants. The methods for hydrolyzing cellulose and hemicellulose can be used on any plant, wood or wood product, wood waste, paper pulp, paper product or paper waste or byproduct.
    Type: Application
    Filed: September 8, 2011
    Publication date: October 17, 2013
    Applicant: SYNGENTA BIOTECHNOLOGY INC.
    Inventors: John Steffens, Paul Oeller, Yoshimi Barron
  • Publication number: 20130273606
    Abstract: The invention relates to a nucleic acid molecule encoding a multimeric precursor which after transcription is specifically cleaved in vivo to form multiple copies of a protein of interest. The invention further relates to a cell comprising this nucleic acid molecule and a method for producing a protein of interest using this cell.
    Type: Application
    Filed: April 18, 2013
    Publication date: October 17, 2013
    Inventors: Anna Cornelia Hendrika VAN HAUTUM, Arjo Lysander DE BOER, Jan Bastiaan BOUWSTRA, Peter Franciscus Theresius Maria VAN ASTEN
  • Publication number: 20130273601
    Abstract: The present invention relates to a yeast cell comprising one or more exogenous genes of a pentose metabolic pathway non-native to the yeast cell wherein the yeast cell has a disruption of the hxk1, hxk2 glk1 and gal1 native in the yeast cell. The invention further relates to pentose and glucose fermenting yeast cell that is capable of simultaneous pentose and glucose consumption.
    Type: Application
    Filed: October 11, 2011
    Publication date: October 17, 2013
    Applicant: DSM IP ASSETS B.V.
    Inventors: Hendrik Wouter Wisselink, Antonius Jeroen Adriaan Van Maris, Jacobus Thomas Pronk
  • Patent number: 8557557
    Abstract: Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods of at least partially degrading, cleaving, or removing polysaccharides, lignocellulose, cellulose, hemicellulose, lignin, starch, chitin, polyhydroxybutyrate, heteroxylans, glycosides, xylan-, glucan-, galactan-, or mannan-decorating groups using isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: October 15, 2013
    Assignee: Battelle Energy Alliance, LLC
    Inventors: David N. Thompson, William A. Apel, Vicki S. Thompson, David W. Reed, Jeffrey A. Lacey
  • Patent number: 8557541
    Abstract: The present invention relates to isolated polypeptides having glucoamylase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
    Type: Grant
    Filed: November 30, 2010
    Date of Patent: October 15, 2013
    Assignees: Novozymes A/S, Novozymes North America, Inc
    Inventors: Sara Landvik, Marc D. Morant, Keiichi Ayabe, Guillermo Coward-Kelly
  • Patent number: 8551754
    Abstract: In one aspect, the invention is directed to polypeptides having an amylase activity, polynucleotides encoding the polypeptides, and methods for making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used as amylases to catalyze the hydrolysis of starch into sugars.
    Type: Grant
    Filed: October 27, 2011
    Date of Patent: October 8, 2013
    Assignee: Verenium Corporation
    Inventors: Kevin Gray, Nahla Aboushadi, James Garrett
  • Patent number: 8546121
    Abstract: Variants of Bacillus sp. no. 707 alpha amylase are provided that are produced more efficiently and thus more economically. Higher fermentation yields are achieved through introducing amino acid variations that promote solubility of the variant in a fermentation broth. Increased solubility allows more enzyme to remain in solution after expression in a host cell. This in turn increases the efficiency with which the expressed variant enzyme can be recovered from the fermentation broth.
    Type: Grant
    Filed: May 29, 2008
    Date of Patent: October 1, 2013
    Assignee: Danisco US Inc.
    Inventors: Wolfgang Aehle, Neelam S. Amin
  • Publication number: 20130243746
    Abstract: This document relates to molecular complexes having acid alpha glucosidase activity and at least one modification that results in enhanced ability of the molecular complex to be transported to the interior of a mammalian cell.
    Type: Application
    Filed: March 14, 2013
    Publication date: September 19, 2013
    Applicant: OXYRANE UK LIMITED
    Inventors: Wouter Vervecken, Kathleen Camilla Telesphore Alida Maria Piens, Jan Robert Ludo Stout, Gwenda Noëlla Pynaert
  • Patent number: 8530215
    Abstract: The present invention relates to a novel protein and a method for the manufacture thereof. The novel protein according to the invention is a recombinant protein with fructanase activity. The recombinant protein according to the invention is an engineered protein derived from recombinant DNA encoding for the protein. The recombinant protein may be or may comprise a fragment of a naturally occurring protein, i.e. of a naturally occurring fructanase protein.
    Type: Grant
    Filed: February 24, 2010
    Date of Patent: September 10, 2013
    Assignee: UWS Ventures Ltd.
    Inventor: Steven Lewis Kelly
  • Publication number: 20130224800
    Abstract: The invention relates to alpha amylases and to polynucleotides encoding the alpha amylases. In addition methods of designing new alpha amylases and methods of use thereof are also provided. The alpha amylases have increased activity and stability at acidic, neutral and alkaline pH and increased temperature.
    Type: Application
    Filed: November 6, 2012
    Publication date: August 29, 2013
    Applicant: VERENIUM CORPORATION
    Inventor: Verenium Corporation
  • Publication number: 20130216655
    Abstract: A food composition comprising a hydrophobin, a protein and/or polysaccharide and a corresponding denaturing enzyme is provided, wherein the activity of the denaturing enzyme has been substantially reduced.
    Type: Application
    Filed: October 12, 2011
    Publication date: August 22, 2013
    Inventor: Andrew Richard Cox
  • Patent number: 8512986
    Abstract: The present invention relates to polypeptides comprising a carbohydrate-binding module amino acid sequence and an alpha-amylase amino acid sequence as well as to the application of such polypeptides.
    Type: Grant
    Filed: December 20, 2010
    Date of Patent: August 20, 2013
    Assignees: Novozymes A/S, Novozymes North America, Inc.
    Inventors: Shiro Fukuyama, Tomoko Matsui, Chee Leong Soong, Eric Allain, Anders Vikso Nielsen, Hiroaki Udagawa, Ye Liu, Junxin Duan, Wenping Wu, Lene Nonboe Andersen, Sara Landvik
  • Patent number: 8507242
    Abstract: Isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius are provided. Further provided are methods of at least partially degrading, cleaving, or removing polysaccharides, lignocellulose, cellulose, hemicellulose, lignin, starch, chitin, polyhydroxybutyrate, heteroxylans, glycosides, xylan-, glucan-, galactan-, or mannan-decorating groups using isolated and/or purified polypeptides and nucleic acid sequences encoding polypeptides from Alicyclobacillus acidocaldarius.
    Type: Grant
    Filed: November 15, 2010
    Date of Patent: August 13, 2013
    Assignee: Battelle Energy Alliance, LLC
    Inventors: David N. Thompson, William A. Apel, Vicki S. Thompson, David W. Reed, Jeffrey A. Lacey
  • Patent number: 8507244
    Abstract: Variants of Bacillus sp. TS-23 strain alpha-amylases exhibit improved enzymatic performance, including increased thermostability, reduced calcium dependence, increased washing/cleaning performance, and baking ability. Compositions comprising these variants are useful in methods of starch processing, starch liquefaction, fermatation, starch saccharification, cleaning, laundrying, textile desizing, baking, and biofilm removal.
    Type: Grant
    Filed: March 2, 2012
    Date of Patent: August 13, 2013
    Assignee: Danisco US Inc.
    Inventors: Andrew Shaw, Sandra Ramer, Scott D. Power, Claudine Chang, Melodie Estabrook, Brian E. Jones, Clement Choy, Marc Kolkmam, Chris Leeflang, Casper Vroeman, Walter Weyler, Karsten Kraugh, Mansi Goyal, Thomas Graycar, Victoria Huang
  • Patent number: 8507243
    Abstract: The present invention relates to an alpha-amylase blend, including a B. stearothermophilus alpha-amylase (AmyS) wherein the amino acid at position S242 is substituted and a B. licheniformis alpha-amylase The invention also relates to processes using the alpha-amylase blends for starch liquefaction and saccharification, ethanol production, and a sweetener production.
    Type: Grant
    Filed: September 11, 2009
    Date of Patent: August 13, 2013
    Assignee: Danisco US Inc.
    Inventors: Bradley A. Paulson, Vivek Sharma, Jayarama K. Shetty
  • Publication number: 20130203128
    Abstract: In alternative embodiments, the invention provides polypeptides having a lignocellulolytic (lignocellulosic) activity, e.g., a ligninolytic and cellulolytic activity, including, e.g., a glycosyl hydrolase, a cellulase, an endoglucanase, a cellobiohydrolase (cbhl) (e.g., an exo-cellobiohydrolase, e.g., having an “exo” activity that can processively release cellobiose units ?-1,4 glucose-glucose disaccharide), a beta-glucosidase, a xylanase, a mannanse, a xylosidase (e.g., a (?-xylosidase) and/or an arabinofuranosidase activity, polynucleotides encoding these polypeptides, and methods of making and using these polynucleotides and polypeptides. In one embodiment, the invention provides thermostable and thermotolerant forms of polypeptides of the invention. The polypeptides and nucleic acids of the invention are used in a variety of pharmaceutical, agricultural and industrial contexts; for example, as enzymes for the bioconversion of a biomass, e.g.
    Type: Application
    Filed: October 6, 2011
    Publication date: August 8, 2013
    Applicant: BP Corporation North America Inc,
    Inventors: Justin T. Stege, Alexander Varvak, John Poland, Chris S. Lyon, Shaun Healey, Peter Luginbuhl
  • Publication number: 20130195835
    Abstract: Described herein are methods and genetically engineered cells useful for producing an altered N-glycosylation form of a target molecule. Also described are methods and molecules with altered N-glycosylation useful for treating a variety of disorders such as metabolic disorders.
    Type: Application
    Filed: September 14, 2012
    Publication date: August 1, 2013
    Applicants: OXYRANE UK LIMITED, UNIVERSITEIT GENT, VIB VZW
    Inventors: Nico Luc Marc Callewaert, Wouter Vervecken, Karen Jacqueline Marcel De Pourcq, Steven Christian Jozef Geysens, Mouna Guerfal
  • Publication number: 20130193070
    Abstract: A zinc compound and methods for use in removing phosphate from water. Preferably the compound is used in removing phosphate from water in swimming pools, spas, and similar structures. Several water treatment techniques are disclosed, as well as a variety of different methods for delivery of the active ingredients. These delivery methods include use of a slurry of the active reagent in solution as well as a tablet, powder, or granulated structure. Additionally, the water treatment techniques may incorporate the use of a combination including both enzymatic compositions and compounds for phosphate removal.
    Type: Application
    Filed: January 18, 2013
    Publication date: August 1, 2013
    Applicant: Natural Chemistry L.P.
    Inventor: Natural Chemistry L.P.
  • Publication number: 20130189197
    Abstract: [PROBLEMS TO BE SOLVED] It is an object of the present invention to provide a gelator containing a long chain oxyaminopolyol capable of forming a gel with a small amount thereof over a liquid property range from acidic to alkaline, and a gel having high environmental suitability, biocompatibility and biodegradability. [MEANS FOR SOLVING THE PROBLEMS] A gelator, characterized by containing a long chain oxyaminopolyol of Formula (I): (where R1 is a C12-16 saturated aliphatic group or a C12-16 unsaturated aliphatic group having one double bond; R2 is a substituent which an amino acid has; and X is an oxygen atom or NH) and a pharmaceutically acceptable salt thereof; a self-assembly formed by the self-assembly of the gelator; and a gel containing the gelator or the self-assembly, and water, an aqueous solution, a hydrophilic organic solvent or a hydrophilic organic solution, or a hydrophobic organic solvent or a hydrophobic organic solution.
    Type: Application
    Filed: March 12, 2013
    Publication date: July 25, 2013
    Applicant: NISSAN CHEMICAL INDUSTRIES, LTD.
    Inventor: NISSAN CHEMICAL INDUSTRIES, LTD.
  • Patent number: 8486681
    Abstract: The present invention relates to variants (mutants) of parent Termamyl-like alpha-amylases, which variant has alpha-amylase activity and exhibits altered properties relative to the parent alpha-amylase.
    Type: Grant
    Filed: January 27, 2009
    Date of Patent: July 16, 2013
    Assignee: Novozymes A/S
    Inventors: Allan Svendsen, Carsten Andersen, Thomas Thisted, Claus Von Der Osten
  • Patent number: 8486390
    Abstract: A therapeutic agent for the treatment of the symptoms of addiction and the method for preparing the therapeutic agent is disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or other method. Further, a method of using of a biomarker, the presence of chymotrypsin in the gastrointestinal tract to determine the presence of symptoms of addiction, and the likelihood of relapsing into addiction is disclosed.
    Type: Grant
    Filed: July 31, 2012
    Date of Patent: July 16, 2013
    Assignee: Curemark LLC
    Inventor: Joan M. Fallon
  • Patent number: 8486664
    Abstract: Ethylenically unsaturated glycosides of formula I wherein Y, Y?, m, A, X, R3 and R4 have the meanings given in the description, are produced by reacting an ethylenically unsaturated compound of formula II with a polysaccharide comprising 10 or more monosaccharide units, such as starch, amylose, amylopectin, cellulose, in the presence of a glycosidase, such as an amylase, cellulase, glucosidase or and galactosidase, or a glycosyltransferase, such a cyclomaltodextrin glucanotransferase.
    Type: Grant
    Filed: July 28, 2011
    Date of Patent: July 16, 2013
    Assignee: BASF SE
    Inventors: Harald Keller, Katja Loos, Wouter Kloosterman
  • Patent number: 8486682
    Abstract: To provide novel ?-amylase derived from a microorganism and a gene thereof. ?-amylase derived from Bacillus flexus is provided.
    Type: Grant
    Filed: April 21, 2009
    Date of Patent: July 16, 2013
    Assignee: Amano Enzyme Inc.
    Inventors: Akiko Matsunaga, Hitoshi Amano, Shotaro Yamaguchi
  • Publication number: 20130164818
    Abstract: Biomass (e.g., plant biomass, animal biomass, microbial, and municipal waste biomass) is processed to produce useful products, such as food products and amino acids.
    Type: Application
    Filed: December 6, 2011
    Publication date: June 27, 2013
    Applicant: XYLECO, INC.
    Inventor: Marshall Medoff
  • Patent number: 8460896
    Abstract: Improved host cells and culture methods involving overexpression of MAN1C1 activity to improve protein production are provided.
    Type: Grant
    Filed: May 21, 2012
    Date of Patent: June 11, 2013
    Assignee: Amgen Inc.
    Inventor: Christopher K. Crowell